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Behavioral/Cognitive

Forebrain Deletion of the Vesicular Acetylcholine
Transporter Results in Deficits in Executive Function,
Metabolic, and RNA Splicing Abnormalities in the Prefrontal
Cortex
Benjamin Kolisnyk,1,2 Mohammed A. Al-Onaizi,1,4 Pedro H. F. Hirata,1 Monica S. Guzman,1,3 Simona Nikolova,1
Shahar Barbash,6 Hermona Soreq,6 Robert Bartha,1,5 Marco A. M. Prado,1,2,3,4 and Vania F. Prado1,2,3,4
1

Robarts Research Institute, 2Graduate Program in Neuroscience, 3Department of Physiology and Pharmacology, 4Department of Anatomy and Cell
Biology, 5Department of Medical Biophysics, Schulich School of Medicine and Dentistry, University of Western Ontario, London, Ontario, Canada, N6A
5K8, and 6Department of Biological Chemistry and The Edmond and Lily Safra Center of Brain Science, The Hebrew University of Jerusalem, Jerusalem
91904, Israel

One of the key brain regions in cognitive processing and executive function is the prefrontal cortex (PFC), which receives cholinergic input
from basal forebrain cholinergic neurons. We evaluated the contribution of synaptically released acetylcholine (ACh) to executive
function by genetically targeting the vesicular acetylcholine transporter (VAChT) in the mouse forebrain. Executive function was assessed using a pairwise visual discrimination paradigm and the 5-choice serial reaction time task (5-CSRT). In the pairwise test, VAChTdeficient mice were able to learn, but were impaired in reversal learning, suggesting that these mice present cognitive inflexibility.
Interestingly, VAChT-targeted mice took longer to reach criteria in the 5-CSRT. Although their performance was indistinguishable from
that of control mice during low attentional demand, increased attentional demand revealed striking deficits in VAChT-deleted mice.
Galantamine, a cholinesterase inhibitor used in Alzheimer’s disease, significantly improved the performance of control mice, but not of
VAChT-deficient mice on the 5-CSRT. In vivo magnetic resonance spectroscopy showed altered levels of two neurochemical markers of
neuronal function, taurine and lactate, suggesting altered PFC metabolism in VAChT-deficient mice. The PFC of these mice displayed a
drastic reduction in the splicing factor heterogeneous nuclear ribonucleoprotein A2/B1 (hnRNPA2/B1), whose cholinergic-mediated
reduction was previously demonstrated in Alzheimer’s disease. Consequently, several key hnRNPA2/B1 target transcripts involved in
neuronal function present changes in alternative splicing in VAChT-deficient mice, including pyruvate kinase M, a key enzyme involved
in lactate metabolism. We propose that VAChT-targeted mice can be used to model and to dissect the neurochemical basis of executive
abnormalities.

Introduction
The prefrontal cortex (PFC) is essential for the modulation of
executive function, which is loosely defined as a set of cognitive
tools that allows hierarchical and timely control of actions leading to specific behaviors (Alvarez and Emory, 2006; Robbins and
Roberts, 2007; Chudasama, 2011). Disruption in executive function is a key symptom in neurological and neuropsychiatric disorders, including Alzheimer’s disease (AD; Perry and Hodges,
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1999; Traykov et al., 2007; McGuinness et al., 2010), schizophrenia (Morice, 1990), autism (Hill, 2004; Sala et al., 2011), and drug
addiction (Stalnaker et al., 2009). The basic neurochemical underpinnings of executive function are, however, still poorly
understood.
Cholinergic deficits are a hallmark of AD (Perry et al., 1977;
Whitehouse et al., 1981, 1982). Moreover, amyloid ␤ (A␤) oligomers, potential toxins in AD, disrupt cholinergic synaptic
transmission in the PFC (Chen et al., 2013). Cholinergic deficiency in AD can have widespread effects, including global
changes in alternative splicing of genes involved in synaptic plasticity (Berson et al., 2012).
Acetylcholine (ACh) in the PFC has been implicated in controlling attention (Elliott, 2003; Jurado and Rosselli, 2007), one of
the components of executive function. Cue detection and topdown modulation of attentive behavior have both been shown to
activate PFC cholinergic activity and to be modulated by cholinergic signaling (Sarter et al., 2001; Parikh et al., 2007). Cholinergic transients in the PFC have been linked to cue detection, and
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both tonic and phasic PFC ACh release seem to regulate attentional demand (Parikh et al., 2007; for review, see Hasselmo and
Sarter, 2011), which may depend mainly on nicotinic receptor
signaling (McGaughy et al., 1999; Grottick and Higgins, 2000;
Parikh et al., 2010; Guillem et al., 2011).
Cognitive flexibility, the ability to alter strategy according to
changing environmental cues, is another key component of executive function (Elliott, 2003; Jurado and Rosselli, 2007). The
neurochemical basis of cognitive flexibility is not fully understood, but serotonin is thought to play critical roles (Schmitt et
al., 2006; Evers et al., 2007; Brigman et al., 2010).
Release of ACh is a tightly regulated process, with the vesicular
acetylcholine transporter (VAChT) controlling a limiting key
step (de Castro et al., 2009a; Kolisnyk et al., 2013; for review, see
Prado et al., 2013). Genetic elimination of VAChT from the forebrain causes deficits in reversal learning assessed using the Morris
Water Maze (MWM) (Martyn et al., 2012). Deficits in reversal
learning may be related to hippocampal dysfunction, but could
also reflect alterations in behavioral flexibility. To examine if decreased levels of VAChT, a change observed in AD (Efange et al.,
1997; Chen et al., 2011), affects executive function we have used
touchscreen tasks. We report that elimination of forebrain
VAChT caused severe deficits in cognitive flexibility and in sustained attention. In addition, we found that these mutant mice
have profound changes in RNA processing in the PFC, which
correlate with behavioral and metabolic deficits. Our results suggest that elimination of forebrain cholinergic activity in mice
provides a model for understanding the neurochemical basis of
executive function.

Materials and Methods
Animals. Generation of VAChT Six3-Cre-flox/flox mice was previously described (Martyn et al., 2012). In short, VAChT Six3-Cre-flox/flox mice were
generated by crossing VAChT flox/flox (mixed C57BL/6J ⫻ 129/SvEv
background, backcrossed to C57BL/6J for five generations) with the
Six3-Cre mouse line (NMRI background, backcrossed to C57BL/6J for
five generations). We then intercrossed VAChT Six3-Cre-flox/wt mice to
obtain VAChT Six3-Cre-flox/flox. For the galantamine experiments, the
mice used were wild-type C57BL/6J. Mice were housed in groups of three
or four per cage without environmental enrichment in a temperaturecontrolled room with 14/10 h light/dark cycle, and water was provided ad
libitum. Only male mice were used in these studies. Mice were restricted
to 85% of their free-feed weight and maintained on 85% of their weight
for the duration of the study. All procedures were conducted in accordance with guidelines from the Canadian Council of Animal Care at the
University of Western Ontario with an approved institutional animal
protocol (2008 –127).
Western blotting. Mouse PFC was collected, protein was isolated, and
immunoblotting was performed as previously described (Martins-Silva
et al., 2011). The antibodies used were anti-VAChT (catalog #139103;
Synaptic Systems) at a 1:3000 dilution, anti-Synaptophysin (catalog
#S5768; Sigma-Aldrich) at a 1:500 dilution, anti-hnRNP A2/B1 (catalog
#sc-10035; Santa Cruz Biotechnology) at a 1:500 dilution, and anti-␤Actin (catalog #ab49900; Abcam), at a 1:15000 dilution. Band intensity
was quantified using FluoroChemQ software (Thermo Fisher Scientific).
ACh release. ACh release from prefrontal cortical brain slices was
quantified by labeling slices with [ 3H] methyl-choline before using KCl
to stimulate release of labeled ACh as previously described (Guzman et
al., 2011).
qPCR. To measure mRNA expression, total RNA was extracted from
freshly dissected PFC tissue, using the Aurum Total RNA for fatty and
fibrous tissue kit (Bio-Rad) according to the manufacturer’s instructions. cDNA synthesis and qPCR analysis were performed as previously
described (Guzman et al., 2011). Primer sequences used to determine
alternative spliced transcripts are found in Table 1. ␤-Actin was used as a
reference transcript for all reactions. For alternative splicing experi-
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Table 1. Primers for alternative splicing assay
Target

Forward primer(5⬘ 3 3⬘)

Reverse primer (5⬘ 3 3⬘)

CD55 exon 8
CD55 exon 1
DRAM2 exon 2
DRAM2 exon 4
SIPA1L1 intron 5
SIPA1L1 exon 4
DYSTONIN exon 41
DYSTONIN exon 7
REELIN exon 3
REELIN exon 18
REELIN exon 1
mENAH
mENAH invasive
PKM1
PKM2

CCCAGCATGTACCTGTTACC
TGTCTCTGTTGCTGCTGTCC
TGATTCAAGGTTCACACTCACA
TTCAGCAAGGCCTCAGTTTT
TCAGGCATGCAGTTCTTTTG
TAGTGTGGACGCTGCTGTCT
ATGGCATTTCCCCCATTAG
GAGCGGGACAAAGTTCAAAA
ATCATGTCCGACCACCAGTT
GCAGTGCCAGACTTTCCTCT
GGCAACCCCACCTACTACG
CGGCAGTAAGTCACCTGTCA
GATTCAAGACCATCAGGTTGTG
CATGCAGCACCTGATAGCTC
GCAGTGGGGCCATTATCGT

TCACATGCAAAACTGTCAAGG
TGCTCAGCAAACTTGGAGTG
AAAACTGAGGCCTTGCTGAA
TCAGGAGGTATTGTCCCTGTG
GAAAGCAGGCAGTACCTTCG
GGCTCTGTGGTCACCAGAAT
GGAGGTTGGTTTTGCTTCAA
CCCGTCCCTCAGATCCTC
ATCATGTCCGACCACCAGTT
GCCTCCCATCTTTGTTGAAA
GACTGGATGCTTGTCGAGGT
C TTCAGCTTTGCCAGCTCTT
CAATGTTGGCCCTAAATAGAA
TTATAAGAGGCCTCCACGCTG
GGGATTTCGAGTCACGGCAA

ments, the alternative exon levels were normalized to a constitutively
expressed exon from the same gene.
Magnetic resonance imaging. Magnetic resonance spectroscopy of the
prefrontal region was performed in four VAChT Six3-Cre-flox/flox mice and
four littermates (VAChT flox/flox). Spectroscopic localization of a 24 l
voxel was achieved by adiabatic selective refocusing (DelaBarre and Garwood, 1998) on a 9.4 tesla horizontal bore small animal Agilent magnetic
resonance imaging (MRI) scanner. Water-suppressed full spectra (TR/
TE ⫽ 3250/20 ms, 128 acquisitions), water-suppressed macromolecule
spectra (TR/TE ⫽ 5000/20 ms, inversion time TI ⫽ 873 ms, 128 acquisitions), and water-unsuppressed spectra (TR/TE ⫽ 3250/20 ms, 8 acquisitions) were acquired. All animals were anesthetized with 2%
isoflurane during the procedure and were maintained at 37° by blowing
warm air into the bore of the magnet using a Model 1025 Small Animal
Monitoring and Gating System (SA Instruments).
Metabolite analysis. Magnetic resonance spectra were analyzed using
purpose-built software (fitMAN; Bartha et al., 1999) to determine the
contribution of each metabolite relative to total creatine as previously
described (Bartha, 2007, 2008). Briefly, spectra were lineshape corrected
(Bartha et al., 2000b) and the macromolecule and residual water contribution was removed (Kassem and Bartha, 2003). Then, the spectrum was
fitted in the time domain to a basis set of 19 metabolite lineshapes
(Pfeuffer et al., 1999; Bartha et al., 2000a). Five metabolites (measured
relative to creatine) were reliably measured and included in group comparisons: N-acetylaspartate (NAA), myo-inositol (Myo), choline (Cho),
taurine (Tau), and lactate (Lac).

Touchscreen behavioral assessment
Apparatus and task. Mice were trained in the 5-choice serial reaction time
task (5-CSRT) and in the pairwise visual discrimination in automated
Bussey–Saksida Mouse Touchscreen Systems model 81426 (Campden
Instruments). Schedules were designed and data were collected using the
ABET II Touch software v.2.15 (Lafayette Instruments).
Pretraining. Before being trained on the pairwise visual discrimination
or the 5-CSRT task, mice were first put through a pretraining program.
This consisted of first habituating the mice to the testing chamber with
the lights off for 15 min. The next day, mice were left in the chamber with
the lights off for 20 min, this time with the reward tray primed with a 150
l reward (strawberry milkshake; Saputo Dairy Products), and a tone
was played whenever the mouse entered the reward tray. Whenever the
mouse returned to the reward tray, it received a reward (7 l) paired with
the tone. This training was repeated the next 2 d for 40 min sessions
(phase 1).
The next training phase (phase 2) involved pairing the reward with the
presentation of the stimulus on the touchscreen. The stimulus appeared
randomly in one of the windows and after 30 s, it was removed and a
reward (7 l) was given paired with a tone. If the mouse touched the
screen while the image was displayed, it immediately received a reward (7
l). Once the mouse collected the reward a new trial was initiated. This
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phase was repeated until the mouse completed
30 trials within 60 min (phase 2).
Phase 3 was used to further shape behavior.
It involved displaying the stimulus randomly
in one of the windows. The mouse was required to touch the stimulus on the screen to
receive a reward (7 l) paired with a tone.
There was no response to the mouse touching
anything but the stimulus. Once again, this was
repeated until the mouse completed 30 trials
within 60 min. Phase 4 was identical to phase 3
except that the mouse was required to initiate
each trial by nose poking the reward tray. Criterion was 30 correct trials within 60 min.
Finally, in the last pretraining phase (phase
5), the previous procedure was repeated but if
the mouse touched an incorrect screen, it received a 5 s time-out, during which the light
was turned on. The final phase had a stricter
criterion, requiring the mouse to perform 30
trials in 60 min with at least 23 correct responses in 2 consecutive days.
Pairwise visual discrimination and reversal.
Pairwise visual discrimination and reversal
task were performed as previously described
(Romberg et al., 2013). Mice used in this experiment were 6 – 8 months old. At the beginning
of each session, the reward tray was primed
with 7 l of milkshake. Briefly, the mice were
first trained to discriminate between two visual
stimuli, which were presented simultaneously,
with their spatial location randomized over a
30 trial session. If mouse nose poked the correct stimulus (S⫹), a tone was played and
mouse received a reward (7 l), whereas if the
incorrect stimulus (S⫺) was nose poked, light
in the chamber was turned on for 5 s (timeout) followed by a correction trial. During the
correction trial, the trial was repeated until the
mouse poked the correct stimulus. Criterion
was reached when the mouse selected the correct image (S⫹) on 80% of the trials, excluding
correction trials, for 2 consecutive days. Once
mice reached criteria, they were given two sessions to assess baseline performance on the
task. For reversal learning the rule associated to
each stimulus was switched, that is, the rewarded image (S⫹) during acquisition became
the (S⫺) image in reversal and was punished,
while the (S⫺) image from acquisition became
the correct stimulus and was rewarded. Reversal learning was assessed over the course of 10
sessions.
Training in 5-CSRT. The 5-CSRT task was
performed as previously described (Romberg
et al., 2011). A distinct cohort of mice (8 –10
months old) was trained in the 5-CSRT task. At
the beginning of each session, the reward tray
was primed with 7 l of milkshake. Each trial
was initiated after the mouse nose poked the
magazine. In this phase, the stimulus was delivered after a variable 5–10 s delay (delay period), during which the animal was required to
attend to the screen. In case the mouse prematurely touched the screen during this delay, the
response was recorded as premature and
the mouse was punished with a 10 s time-out.
The stimulus duration was initially set to 4 s,
followed by a limited holding period of 5 s,
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Figure 1. Expression of VAChT in the PFC of VAChT Six3-Cre-flox/flox mice. A, VAChT protein expression in the PFC with representative immunoblots inset (n ⫽ 4). B, Release of newly synthesized [ 3H]ACh in PFC slices (n ⫽ 3). C, qPCR analysis of nAChR
expression (n ⫽ 6, data are mean ⫾ SEM, *p ⬍ 0.05).

Figure 2. VAChT Six3-Cre-flox/flox mice show normal visual discrimination learning. A, Mean number of trials required to reach criteria
during the operant conditioning, pretraining phases. B, Image of a mouse performing the task, with the fan shown as the S⫹ and the
marblesastheS⫺.C,Numberofsessionstocriteriainthepairwisevisualdiscriminationlearningtask.D,Correctionerrorsmadetoachieve
discrimination criteria. E, Mean response latency. F, Mean reward collection latency. n ⫽ 8, data are mean ⫾ SEM.
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reward tone, was played semirandomly at five
different time points during the delay period: 0
(corresponding to when the mouse initiates the
task), 0.5, 2.5, 4.5, and 5 s (corresponding to
when the stimulus is displayed on the touchscreens). Stimulus duration was set to 2 s. For
each distractor tone time point mice were
tested for five sessions. At the end of the five
sessions one baseline task (50 trial, 2 s stimulus
duration, no distractor sounds) was performed
before moving to the next distractor time
point.
5-CSRT task measures. On all 5-CSRT task
sessions, accuracy was defined as the total
number of correct responses, divided by the
number of correct and incorrect (touches to a
wrong window while the correct stimulus was
still displayed) responses. The rate of omissions was the proportion of omitted responses
to total trials. Response latency was the time for
the mouse to touch the correct stimulus after
its onset. Reward collection latency was the
time for the mouse to return to the reward tray
once it had touched the correct stimulus. A
premature response was counted when the
mouse touched one of the windows before
stimulus onset. Finally, a perseverative response was any identical response that occurred following a correct, incorrect, or
premature response.
Drug treatment. Galantamine hydrobromide, a cholinesterase inhibitor, (SigmaAldrich) was dissolved in physiological saline
(0.9% NaCl) before administration. Sixty minutes before being tested on the 5-CSRT mice
received an intraperitoneal injection of drug
Figure 3. VAChT Six3-Cre-flox/flox mice have impaired reversal learning. A, Image of a mouse performing the task, this time with (100 l, 1 mg/kg) or saline. The dose for galanthe fan shown as the S⫺ and the marbles as the S⫹. B, Choice accuracy before (B1 and B2) and during reversal trials (R2–R10), tamine was selected based on previous studies
dashed line denotes chance (50%). C, Number of correction errors made across reversal trials. D, Response latency across reversal (Prado et al., 2006; de Castro et al., 2009b; De
trials. E, Reward collection latency across reversal trials (n ⫽ 8, data are mean ⫾ SEM, *p ⬍ 0.05, **p ⬍ 0.01, and ***p ⬍ 0.001). Jaeger et al., 2013). Previously, we have tested 3
mg/kg galantamine in other tasks, but this dose
was no more effective than 1 mg/kg and it produced hypersalivation in mice (de Castro et al.,
during which the stimulus was absent, but the mouse could still respond
2009b). Moreover, at 1 mg/kg wild-type mice were able to increase their
to the location (holding period). Responses to the stimulus window durperformance in the 5-CSRT (see below). Mice were tested at the 0.6 s
ing stimulus presence or the holding period were recorded as correct and
stimulus duration, which represents a high attention demanding task
a 7 l reward was administered, while responses to any other window
(Romberg et al., 2011). The order of the injections was counterbalanced.
were recorded as incorrect. A correct choice was rewarded with a tone
Between injections mice had three washout days wherein their perforand food delivery. An incorrect response was punished with a 10 s timemance on the 5CSRT was re-baselined at the 2 s stimulus duration.
out. A failure to respond to any window either during stimulus display,
Statistical analysis. For the pairwise visual discrimination task response
or during the holding period, was recorded as an omission and punished
accuracy was calculated as the number of correct trials divided by the
with a 10 s time-out. Perseverative responses to the screen after prematotal number of trials, excluding correction trials. Data are expressed as
ture, correct, and incorrect choices were also recorded. Once the performean ⫾ SEM. SigmaStat 3.5 software was used for statistical analysis.
mance of a mouse reached criterion at 4 s stimulus duration (80%
Comparison between two experimental groups was made by Student’s t
accuracy, 20% omissions for 3 consecutive days), the stimulus duration
test or Mann–Whitney rank sum test, when the data did not follow a
was reduced to 2 s. After reaching criterion with the 2 s stimulus, mice
normal distribution. When several experimental groups or treatments
were tested for two more days. The mean measurement of those 2 d was
were analyzed, two-way ANOVA or two-way ANOVA with repeated
used to assess baseline performance. If the mouse completed ⬍30 trials,
measures was used as required. When appropriate, a Tukey’s HSD post
it was considered not to have reached criteria, even if it met accuracy and
hoc comparison test was used. In all comparisons, p ⬍ 0.05 was considomissions thresholds.
ered statistically significant.
Probe trial. To probe attention in mice we used a previously described
probe trial schedule with reduced stimulus durations (Romberg et al., 2011).
Briefly, each mouse was tested for 2 consecutive days at a given stimulus
Results
duration (1.5, 1, 0.8, and 0.6 s). After each test, the animal was retested onto
VAChT Six3-Cre-flox/flox mice have reduced VAChT and ACh
the 2 s stimulus duration for 2 d or until criteria were reached (80% accuracy,
release in the PFC
20% omission), to assess baseline performance. The order of the probe trial
We have previously reported that VAChT Six3-Cre-flox/flox mice
sessions were semirandomized using a Latin square method.
have the VAChT gene deleted from ⬎90% of their basal forebrain
Distraction task. To further test attentional demand, and assess suscepcholinergic neurons (Martyn et al., 2012). To confirm that this
tibility to distraction, we developed a distraction version of the 5-CSRT
task. During this task, a 1000 ms distractor tone, different from the
deletion affected prefrontal cortical cholinergic signaling, we per-
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formed Western blot analysis to assess VAChT expression.
VAChT Six3-Cre-flox/flox mice have a significant reduction in PFC
VAChT protein expression (t(6) ⫽ 2.706, p ⫽ 0.0353; Fig. 1A).
Moreover, this reduction in VAChT protein levels results in a
significant decrease in newly synthesized [ 3H] ACh release in
slices of PFC from VAChT Six3-Cre-flox/flox mice when compared
with control mice (t(4) ⫽ 2.899, p ⫽ 0.0442; Fig. 1B). We used
qPCR to assess the expression of nicotinic receptors (nAChRs),
which have been shown previously to be critical for attentional
performance. The PFC of VAChT Six3-Cre-flox/flox mice shows no
significant change in the expression of ␣7nAChR mRNA (t(10) ⫽
0.9300, p ⫽ 0.3743) nor ␤2nAChR mRNA (t(10) ⫽ 0.8359, p ⫽
0.4227). Interestingly, ␣4nAChR mRNA is slightly upregulated
(t(10) ⫽ 2.550, p ⫽ 0.0289; Fig. 1 C).
Decreased forebrain cholinergic tone specifically disturbs
reversal learning in the pairwise visual discrimination task.
We have previously demonstrated that VAChT Six3-Cre-flox/flox
mice have impairments in reversal learning in the MWM
(Martyn et al., 2012), suggesting the possibility that these mice
have behavior flexibility deficits. To determine whether
VAChT Six3-Cre-flox/flox mice present alterations in cognitive flexibility we used a “nonhippocampal” pairwise visual discrimination task (Romberg et al., 2013). This task has been previously
shown to depend on the PFC and also on striatal-cortical loops
(Graybeal et al., 2011). The performance of VAChT Six3-Cre-flox/flox
mice did not differ from that of controls (VAChT flox/flox) when
they were trained to operate the touchscreen (pretraining phase).
The number of sessions the mice took to acquire each training
phase did not differ from control (RM-ANOVA, no effect of
genotype F(1,54) ⫽ 0.3950, p ⫽ 0.5398; main effect of training
phase F(4,54) ⫽ 5.227, p ⫽ 0.0012; and no interaction effect F(4,54) ⫽
1.389, p ⫽ 0.2495; Figure 2A). Acquisition of the pairwise visual
discrimination task (Fig. 2B; for stimuli used) did not differ
between genotypes, in terms of sessions to criteria (Fig. 2C; t(14) ⫽
0.2446, p ⫽ 0.8117), correction errors made (Fig. 2D; t(14) ⫽
0.2942, p ⫽ 0.7746), response latency (Fig. 2E; t(14) ⫽ 1.019,
p ⫽ 0.3256), or reward collection latency (Fig. 2F; t(14) ⫽ 0.2606,
p ⫽ 0.7988). We have previously reported that these mice are
hyperactive in novel environments, but they are able to habituate
to the environment (Martyn et al., 2012). Hence, due to the extensive training for the performance in the touchscreen tasks the
lack of differences in response and reward collection latencies is
not surprising. However, VAChT Six3-Cre-flox/flox mice showed severe reversal learning impairment (Fig. 3A; for the stimuli used),
measured by the percentage of correct responses (Fig. 3B; RMANOVA, main effect of genotype F(1,132) ⫽ 19.78, p ⫽ 0.0008;
main effect of session F(11,132) ⫽ 23.28, p ⫽ 0.0001; and significant interaction effect F(1,12) ⫽ 5.035, p ⫽ 0.0001) and by its
increased correction errors (Fig. 3C; RM-ANOVA, main effect of
genotype F(1,132) ⫽ 14.72, p ⫽ 0.0024; main effect of session
F(11,132) ⫽ 14.37, p ⫽ 0.0001; and significant interaction effect
F(1,12) ⫽ 2.817, p ⫽ 0.0025). Post hoc analysis showed that
VAChT Six3-Cre-flox/flox mice never improved significantly from
the first reversal session and in 10 sessions they performed only
at chance level. Importantly, during the reversal trials, the
VAChT Six3-Cre-flox/flox mice did not differ from controls in terms
of response latency (Fig. 3D; RM-ANOVA, no effect of genotype
F(1,154) ⫽ 0.4233, p ⫽ 0.5258; main effect of session F(11,154) ⫽
4.705, p ⫽ 0.0001; and no interaction effect F(11,154) ⫽ 0.9997, p ⫽
0.4493) or reward collection latency (Fig. 3E; RM-ANOVA, no
effect of genotype F(1,154) ⫽ 1.107, p ⫽ 0.3105; main effect of
session F(11,132) ⫽ 3.965, p ⫽ 0.0001; and no interaction effect

Figure 4. Training in the 5-CSRT task. A, Mean number of trials required to reach criteria
during the operant conditioning, pretraining phases. B, Mean number of trials required to reach
criteria at 4 and 2 s stimulus duration (n ⫽ 6, data are mean ⫾ SEM, *p ⬍ 0.05).

F(11,154) ⫽ 1.141, p ⫽ 0.3333). These results suggest that forebrain
cholinergic tone is important for cognitive flexibility.
VAChT Six3-Cre-flox/flox mice have impaired acquisition of the
5-CSRT task
Similar to the results for visual discrimination experiments, the
performance of the second cohort of VAChT Six3-Cre-flox/flox mice
did not differ from that of control mice for touchscreen operation
training (pretraining phase). The number of sessions necessary to
reach criteria across all pretraining phases did not differ between
genotypes (RM-ANOVA, no effect of genotype F(1,32) ⫽ 1.528,
p ⫽ 0.2515; no effect of training phase F(4,32) ⫽ 1.492, p ⫽ 0.2280;
Figure 4A). However, when mice were trained to respond to
flashes of light displayed in one of the five spatial locations on the
touchscreen (training phase), VAChT Six3-Cre-flox/flox showed a
significantly worse performance, needing more sessions to reach
criteria (RM-ANOVA, main effect of genotype, F(1,8) ⫽ 10.06,
p ⫽ 0.0132; main effect of stimulus duration, F(1,8) ⫽ 5.731, p ⫽
0.0436, no interaction effect, F(1,8) ⫽ 4.252, p ⫽ 0.0731; Fig. 4B).
Deletion of forebrain VAChT results in inattentive but not
impulsive or compulsive behavior
Once mice reached criteria they were tested for attentional performance by decreasing stimulus duration to 1.5, 1, 0.8, and 0.6 s
as previously described (Romberg et al., 2011). At 1.5 s,
VAChT Six3-Cre-flox/flox mice were able to perform identically to
control mice in both accuracy and omissions (Fig. 5 A, B). In
contrast, increasing attentional demand by diminishing the stimuli period revealed an attentional deficit in VAChT Six3-Cre-flox/flox
mice. Response accuracy did not differ between genotypes (RMANOVA, no effect of genotype F(1,24) ⫽ 0.0007548, p ⫽ 0.9788;
main effect of stimulus duration F(3,24) ⫽ 10.28, p ⬍ 0.001; Figure
5A). However, VAChT Six3-Cre-flox/flox mice presented an increased rate of omission (RM-ANOVA, main effect of genotype
F(1,24) ⫽ 57.99, p ⬍ 0.0001; main effect of stimulus duration
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Figure 5. VAChT Six3-Cre-flox/flox mice have attentional deficits. Performance and response measures during 5-CSRT task probe trials. Mice were subjected to a series of probe trials and the average
values of 50 trial sessions are plotted. A, Mean accuracy. B, Mean rate of omissions. C, Mean premature responses. D, Mean perseverative responses. E, Mean response latency. F, Mean reward
collection latency (n ⫽ 6, data are mean ⫾ SEM, *p ⬍ 0.05 and **p ⬍ 0.01).

from littermate controls in response latency (RM-ANOVA, no effect of genotype
F(1,24) ⫽ 2.279, p ⫽ 0.1818; no effect of
stimulus duration F(3,24) ⫽ 0.09686, p ⫽
0.7662; Figure 5E) and reward collection
latency (RM-ANOVA, no effect of genotype F(1,24) ⫽ 2.279, p ⫽ 0.1818; no effect
of stimulus duration F(3,24) ⫽ 1.189, p ⫽
0.3420; Figure 5F ).

Deletion of forebrain VAChT impairs
sustained attention
To assess sustained attention (vigilance), we analyzed both response accuracy and rate of omissions over blocks of
10 trials (Romberg et al., 2011). Response accuracy of control mice did not
significantly vary across blocks, but did
reduce significantly with decreases in
stimuli duration (RM-ANOVA, main
effect of stimulus duration F(3,48) ⫽
5.893, p ⫽ 0.0104; no effect of block
Figure 6. VAChT Six3-Cre-flox/flox mice have impaired sustained attention. Mean response accuracy for blocks of 10 trials for (A) F(4,48) ⫽ 1.214, p ⫽ 0.317; Figure 6A). In
response
accuracy
of
VAChT flox/flox and (B) VAChT Six3-Cre-flox/flox mice. Mean rate of omission for blocks of 10 trials for (C) VAChT flox/flox and (D) contrast,
VAChT Six3-Cre-flox/flox mice reduced sigVAChT Six3-Cre-flox/flox mice (n ⫽ 6, data are mean ⫾ SEM, *p ⬍ 0.05).
nificantly across blocks and stimuli duration (RM-ANOVA, main effect of
F(3,24) ⫽ 36.44, p ⬍ 0.0001; no interaction effect F(3,24) ⫽ 2.176,
stimulus duration F(3,48) ⫽ 4.257, p ⫽ 0.0077; main effect of
p ⫽ 0.1171; Figure 5B). Post hoc analysis revealed that
block F(4,48) ⫽ 3.933, p ⫽ 0.0289; Figure 6B). As with response
VAChT Six3-Cre-flox/flox mice omitted more at 0.6 –1 s stimulus
accuracy, rate of omissions of control mice did not vary across
durations. Interestingly, VAChT-deficient mice had no
blocks, only with stimuli duration (RM-ANOVA, main effect
alterations in premature responses (RM-ANOVA, no effect of
of stimulus duration F(3,48) ⫽ 5.803, p ⫽ 0.0228; no effect of
genotype F(1,24) ⫽ 0.07440, p ⫽ 0.7874; no effect of stimulus
block F(4,48) ⫽ 0.5352, p ⫽ 0.7105; Figure 6C), whereas rate of
duration F(3,24) ⫽ 0.9891, p ⫽ 0.4146; Figure 5C) or perseverative
omissions of VAChT Six3-Cre-flox/flox mice increased signifiresponses (RM-ANOVA, no effect of genotype F(1,24) ⫽ 0.04610,
cantly across stimuli duration and blocks (RM-ANOVA, main
p ⫽ 0.9695; no effect of stimulus duration F(3,24) ⫽ 1.244, p ⫽
0.3232; Figure 5D). Additionally, mutant mice did not differ
effect of stimulus duration F(3,48) ⫽ 9.387, p ⫽ 0.0018; main
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effect of block F(4,48) ⫽ 2.803, p ⫽
0.0360; Figure 6D). Together the data
suggest that VAChT Six3-Cre-flox/flox mice
have impaired ability to sustain
attention.
Deletion of forebrain VAChT increases
susceptibility to distractions
To assess distractibility of VAChT Six3-Cre-flox/
flox mice, we increased attentional demand
by testing them on a distraction variation of
the 5-CSRT. Stimulus duration was set to
2 s, where performance of both genotypes
was identical, and distractor sounds were
played at set time points during trials. Response accuracy of VAChT Six3-Cre-flox/flox
mice tended to be reduced by distractions
compared with controls (RM-ANOVA,
near significant effect of genotype F(1,32) ⫽
4.825, p ⫽ 0.0589; main effect of distractor
onset F(4,32) ⫽ 3.583, p ⫽ 0.0159; Figure
7A). Rate of omission was significantly
higher in VAChT Six3-Cre-flox/flox mice than
controls (RM-ANOVA, significant effect of
genotype F(1,32) ⫽ 6.809, p ⫽ 0.0312; no ef- Figure 7. VAChT Six3-Cre-flox/flox mice are more susceptible to distraction. Mice were subjected to a series of distraction trials and
fect of distractor onset F(4,32) ⫽ 2.564, p ⫽ the average values of 50 trial sessions per distractor onset are plotted. A, Mean response accuracy. B, Mean rate of omission. C,
0.0572; Figure 7B). Importantly, neither re- Mean response latency. D, Mean reward collection latency (n ⫽ 6, data are mean ⫾ SEM, * represents significant differences
sponse latency (RM-ANOVA, no effect of between genotypes, # represents significant differences within genotypes; *p ⬍ 0.05).
genotype F(1,32) ⫽ 1.045, p ⫽ 0.3367; main
effect of distractor onset F(4,32) ⫽ 7.069, p ⫽
t(7) ⫽ 0.390, p ⫽ 0.7080) were not changed by galantamine injec0.0003; Figure 7C) nor reward collection latency varied between getions (data not shown). These results suggest that increased chonotypes (RM-ANOVA, no effect of genotype F(1,32) ⫽ 0.7467, p ⫽
linergic tone can increase attentional performance when the
0.4127; main effect of distractor onset F(4,32) ⫽ 3.226, p ⫽ 0.0248;
probe trial is sufficiently demanding to avoid a potential ceiling
Figure 7D).
effect.
Galantamine improves attention in wild-type mice on a
demanding task
Detection of pro-attentive effects of pharmacological manipulations on the 5-CSRT is hampered by possible ceiling effects (Robbins, 2002). To detect differences in mice it is important to test
the drug on challenging conditions, which can be achieved by
shortening the duration of the stimulus presentation (Romberg
et al., 2011). To find a suitably challenging task in which we could
observe increased attention, we trained a group (n ⫽ 8) of wildtype mice on the 5-CSRT, and ran them through the probe trial
series, serially reducing stimulus duration (1.5, 1, 0.8, and 0.6 s).
Choice accuracy (F(4,31) ⫽ 13.77, p ⬍ 0.0001; Fig. 8A) and rate of
omissions (F(4,31) ⫽ 6.716, p ⫽ 0.0024; Fig. 8B) were significantly
affected by reducing stimulus duration. Post hoc analysis revealed
that at 0.6 s stimulus duration the rate of accuracy was significantly reduced, and omissions significantly increased from the
1.5 s stimulus duration. We therefore chose both, 0.8 s stimulus
duration and the more challenging 0.6 s stimulus duration, for
pharmacological testing. Administration of galantamine (1 mg/
kg, i.p.) 1 h before 5-CSRT testing at 0.8 s did not improve accuracy (paired t test, t(7) ⫽ 1.287, p ⫽ 0.2544; Fig. 8C) or omissions
(paired t test, t(7) ⫽ 0.4581, p ⫽ 0.6661; Fig. 8D). However, when
administered before a 0.6 s stimulus duration session, galantamine (1 mg/kg) significantly improved accuracy compared
with saline (paired t test, t(7) ⫽ 2.405, p ⫽ 0.0471; Fig. 8E) and
significantly reduced the rate of omission (paired t test, t(7) ⫽
2.379, p ⫽ 0.0489;Fig. 8F ). Response latency (paired t test, t(7) ⫽
1.296, p ⫽ 0.2360), and reward collection latency (paired t test,

Galantamine does not improve attention deficits in
VAChT Six3-Cre-flox/flox mice
To investigate if the deficits observed in VAChT Six3-Cre-flox/flox are
exclusively related to decreased levels of synaptic ACh, we injected mice with galantamine (1 mg/Kg IP), a dose that effectively
improved performance of wild-type mice (Fig. 8), and tested
both VAChT Six3-Cre-flox/flox and VAChT flox/flox mice at 0.6 s (50
trials). Galantamine tended to improve choice accuracy, albeit
this effect did not reach statistical significance (paired t test, t(5) ⫽
1.954, p ⫽ 0.1224; Fig. 8G). However, the drug was able to significantly reduce rate of omissions (paired t test, t(5) ⫽ 3.383, p ⫽ 0.0277;
Fig. 8H) in VAChT flox/flox mice. Interestingly, galantamine had no
effect on the performance of VAChT Six3-Cre-flox/flox mice, neither improving accuracy (paired t test, t(5) ⫽ 0.162, p ⫽ 0.880; Fig. 8G) nor
rate of omission (paired t test, t(5) ⫽ 0.868, p ⫽ 0.434; Fig. 8H).
Deletion of forebrain VAChT results in metabolic
abnormalities in the PFC
The lack of effect of galantamine in VAChT Six3-Cre-flox/flox suggests that diminished ACh release in mutant mice may not be
sufficiently increased by galantamine to reverse the attentional
deficits in these mice. In addition to that, a chronic decrease in
cholinergic tone may cause circuitry or metabolic changes that
could affect how neuronal circuitries are recruited for specific
cognitive tasks. We used in vivo magnetic resonance spectroscopy
to assess if metabolic parameters were affected in the prefrontal
region of VAChT-deficient mice (Fig. 9A; representative spectra).
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Figure 8. Galantamine improves attention in wild-type, but not in VAChT Six3-Cre-flox/flox mice. Wild-type mice (n ⫽ 8) were subjected to a series of probe trials and the average values of 50 trial
sessions are plotted. A, Mean accuracy. B, Mean rate of omissions. Effect of galantamine (1 mg/kg i.p.) on (C) response accuracy and (D) rate of omission in wild-type mice at a 0.8 s stimulus duration
(n ⫽ 8). Effect of galantamine on (E) response accuracy and (F ) rate of omission in wild-type mice at a 0.6 s stimulus duration (n ⫽ 8). Effect of galantamine (1 mg/Kg I.P.) on (G) choice accuracy
and (H ) rate of omission in VAChT flox/flox and VAChT Six3-Cre-flox/flox mice (n ⫽ 6, data are mean ⫾ SEM, *p ⬍ 0.05).

This analysis revealed that VAChT Six3-Cre-flox/flox mice had significantly less Lac (t(6) ⫽ 2.600, p ⫽ 0.0428; Fig. 9B) and Tau
(t(6) ⫽ 2.522, p ⫽ 0.0452; Fig. 9C) than controls. Levels of NAA
(t(6) ⫽ 0.0907, p ⫽ 0.9307; Fig. 9D), Myo (t(6) ⫽ 0.9598, p ⫽
0.3742; Fig. 9E), and Cho (t(6) ⫽ 0.1461, p ⫽ 0.8886; Fig. 9F )
remained unchanged.
Deletion of forebrain VAChT results in altered RNA
metabolism in the PFC
Cholinergic deficits in AD have been proposed to cause major
transcriptome changes via aberrant hnRNPA2/B1 expression
(Berson et al., 2012). hnRNPA2/B1 refers to a family of proteins
that functions as splicing factors and mRNA chaperones (Hoek et
al., 1998; Kamma et al., 1999). This gene family is critical for
regulating alternative splicing in numerous genes involved with
synaptic plasticity and cognition (Berson et al., 2012). Its expression is severely reduced in Alzheimer brain and appears enhanced
in primary mouse neurons under carbachol induction (Berson et
al., 2012), suggesting cholinergic regulation of hnRNPA2/B1 proteins. To determine whether the PFC of VAChT Six3-Cre-flox/flox
shows parallel suppression of the hnRNPA2/B1 proteins, their
levels were assessed. Compared with controls, the PFC of
VAChT Six3-Cre-flox/flox mice showed a significant reduction in hnRNPA2/B1 expression (75% decrease, t(6) ⫽ 4.941, p ⫽ 0.0026;
Fig. 10A). We then used qPCR to assess whether the decrease in
hnRNPA2/B1 could have a functional impact on RNA processing
in the PFC. We evaluated the alternative splicing of the key genes,
SIPA1L1(SIPA), REELIN(RELN), DRAM2, CD55, DYSTONIN

(DST), and ENAH, as manifested by increased exon inclusion
tested both in Alzheimer’s brain and in mouse brain depleted of
its cholinergic neurons by saporin-mediated treatment (Berson
et al., 2012). This analysis revealed that VAChT Six3-Cre-flox/flox
mice had significant changes in the splicing of these genes in the
PFC, with significantly increased inclusion of exon 8 of CD55
(t(10) ⫽ 2.550, p ⫽ 0.0289), exon 41 of DST (t(10) ⫽ 7.436, p ⫽
0.0001), exon 18 of RELN (t(10) ⫽ 3.230, p ⫽ 0.0090), and exon 2
of DRAM2 (t(10) ⫽ 3.990, p ⫽ 0.0260). In addition the inv isoform of the ENAH gene was also significantly increased (t(10) ⫽
2.522, p ⫽ 0.0303). In contrast, intron 5 of SIPA (t(10) ⫽ 0.5449, p ⫽
0.5978) and exon 3 of RELN (t(10) ⫽ 2.215, p ⫽ 0.0511), which have
also been shown to be affected in AD, were unchanged, although we
detected a trend for the latter (Fig. 10B).
hnRNPA2/B1 has been shown to regulate the splicing of
pyruvate kinase M (PKM) enzyme, which in turn dictates lactate metabolism (David et al., 2010). Knockdown of hnRNPA2/B1 expression in vitro favors the PKM1 isoform,
which leads to reduced levels of Lac, whereas upregulation
hnRNPA2/B1 favors the PKM2 isoform and increased Lac levels (Clower et al., 2010; for review, see Chen et al., 2010). To
test whether alternative splicing of PKM occurs in VAChT Six3Cre-flox/flox mice, we performed qPCR to determine the expression
of the PKM1 and PKM2 splice variants. Interestingly the
VAChT Six3-Cre-flox/flox mice showed a significant upregulation of
the PKM1 variant (t(10) ⫽ 4.277, p ⫽ 0.0016), and a significant
reduction in the PKM2 variant (t(10) ⫽ 3.073, p ⫽ 0.0110; Fig.
10C), effectively changing the ratio between these two enzymes.
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Discussion
In this report we show that forebrain
VAChT knock-out mice present deficits
in two domains of executive function,
cognitive flexibility and attention. Additionally, VAChT-deficient mice exhibit
metabolic deficits in the PFC suggestive of
changes in PFC circuitry. Furthermore,
these mice have reduced expression of a
key splicing factor, hnRNPA2/B1, which
has been previously implicated in synaptic
plasticity deficits in AD (Berson et al.,
2012) and in mutations that were recently
discovered in rare proteinopathies (Kim
et al., 2013). These changes have a functional impact on RNA metabolism in the
PFC of VAChT-deficient mice. These results suggest that VAChT Six3-Cre-flox/flox
mice may represent a powerful tool to dissect the molecular and neurochemical basis of executive dysfunction.
Cognitive flexibility in
VAChT Six3-Cre-flox/flox mice
VAChT Six3-Cre-flox/flox mice were able to
associate an image with a reward, and another with a punishment, in the pairwise
visual discrimination task. Acquisition of
this task has been shown to be dependent
on glutamatergic signaling, with mice
lacking the GLAST glutamate transporter
Six3-Cre-flox/flox
mice have metabolic abnormalities in the PFC. In vivo magnetic resonance spectroscopy of
being unable to acquire the task (Karlsson Figure 9. VAChT
neuronal metabolites. A, 9.4 tesla 1H magnetic resonance spectroscopy data from VAChT flox/flox (top) and VAhT six3cre-flox/flox
et al., 2009). Evidence suggests that the
(bottom) mice. The VAChT flox/flox data are shown in gray with fit superimposed (black line) and residual shown above. Individual
NMDA receptor is an important molecu- component spectra for Tau and Lac are also provided. B, Levels of Lac. C, Levels of Tau. D, Levels of NAA. E, Levels of Myo. F, Levels
lar switch for the acquisition of the task of Cho (n ⫽ 4, data shown are the median and individual values per mouse, *p ⬍ 0.05).
(Brigman et al., 2008; Barkus et al., 2012).
Our results indicate that cholinergic sigfinding with the VAChT Six3-Cre-flox/flox mouse line having learnnaling is not required for such learning. In contrast, when coning and memory deficits (Martyn et al., 2012), these mice showed
tingencies of the pairwise task were reversed, forebrain VAChT
impairments in acquisition of the 5-CSRT, taking nearly twice as
knock-out mice were unable to adapt and learn the new rule.
long as controls to reach criteria at the 4 and 2 s phase of the
Reversal learning in a visual discrimination task has been protraining process. Interestingly, they were not impaired during the
posed to serve as a measure of cognitive flexibility in rodents
pretraining phase, wherein mice are taught to respond to the
(Izquierdo et al., 2006; Brigman et al., 2008). Neurochemical
touchscreen. These results suggest that simple operant condimodulation of reversal learning is complex, as it can be entioning is not dependent on forebrain cholinergic signaling, but
hanced by targeting multiple neurotransmitter signaling systems inrather that forebrain ACh is responsible for the use of such inforcluding serotonergic (Brigman et al., 2010), dopaminergic
mation to perform higher order cognitive tasks. Attentional de(Izquierdo et al., 2006), and glutamatergic (Balschun et al., 2010).
mand deficits were probed by reducing stimulus duration.
The role of cholinergic signaling has been focused predominantly on
Choice accuracy, perseverative, and premature responses of
muscarinic receptors (Ridley et al., 1984, 1985). Determining the
VAChT Six3-Cre-flox/flox mice were unaffected. However, the rate
exact mechanism has been difficult, as M1 receptor agonists facilitate
of omission for VAChT Six3-Cre-flox/flox was significantly incognitive flexibility (McCool et al., 2008; Shirey et al., 2009), but no
creased. Additionally, in the presence of a noise distractor
effects on cognitive flexibility were observed in M1-null mice
VAChT Six3-Cre-flox/flox mice were significantly less attentive than
(Bartko et al., 2011). There is evidence suggesting that M2 and M4
controls, showing a much higher rate of omissions. This test was
receptors may be involved in cognitive flexibility (Nieves-Martinez
performed under a condition in which the performance of
et al., 2012). Our results indicate that cholinergic signaling is essenVAChT-deficient mice was on par with controls without the autial for modulation of cognitive flexibility.
ditory distraction. The auditory distraction task gives a clear indication that the attention deficits observed in VAChT Six3-CreAttention deficits in VAChT-deficient mice
flox/flox
mice were not due to visual abnormalities. These findings
To further understand the role of forebrain ACh in executive funcare aligned with previous work, given that cue detection has been
tion we evaluated attention on forebrain VAChT knock-out
shown to involve transient rises in ACh release (Himmelheber et
mice using the 5-CSRT task, a test suggested to be dependent on
al., 2000; Parikh et al., 2007). Our experiments agree with previPFC cholinergic signaling (Guillem et al., 2011; for review, see
ous work indicating a key role for cholinergic activity in improvRobbins, 2000; Dalley et al., 2004a). In line with our previous
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ing response to distractors in attentional
tasks (Gill et al., 2000; Terry et al., 2002;
Newman and McGaughy, 2008; Broussard et al., 2009; Howe et al., 2010; St Peters et al., 2011).
Regulation of attentional performance
by endogenous ACh has been investigated
in rats using immunolesion with IgG-192
saporin (Walsh et al., 1996; Risbrough et al.,
2002; Lehmann et al., 2003; Chudasama et
al., 2004; Dalley et al., 2004b). Specifically,
deficits in choice accuracy and increases in
perseverative responses were observed in
rats following 192 IgG-saporin-induced lesions (McGaughy et al., 2002; Dalley et al.,
2004b). In these studies no effects were observed on rates of omissions. Our experiments show a somewhat distinct feature,
demonstrating increased rates of omission,
without changes in perseverative response.
Interestingly, selective elimination of the ␤2
nAChR in mice also revealed an increase in
rate of omissions (Guillem et al., 2011). The
differences between genetically modified
and lesioned animals could therefore be
species related. Alternatively, this difference
may reflect the capacity of cholinergic neurons to secrete more than one neurotransmitter (El Mestikawy et al., 2011; Prado et
al., 2013). Basal forebrain cholinergic neurons can release glutamate in vitro (Allen et
al., 2006). There is also evidence that these
neurons possess the machinery to release
GABA (Henny and Jones, 2008). Recent experiments targeting striatum cholinergic
neurons revealed striking behavioral differences between mice that had cholinergic
elimination, using immunolesion, or mice
that were genetically targeted to eliminate
striatal ACh release (Kitabatake et al., 2003;
Guzman et al., 2011; for review, see Prado et
al., 2013). Immunolesion of cholinergic
neurons can therefore have effects beyond
impairing ACh release and could affect
cotransmission. Whether cotransmission
has a role in the small phenotypic differences between our experiments and previous work using rats injected with IgG-192saporin remains to be determined.

Figure 10. VAChT Six3-Cre-flox/flox mice have abnormal RNA processing in the PFC. A, hnRNPA2/B1 protein expression in
the PFC with representative immunoblots (inset, n ⫽ 4). B, qPCR analysis of alternative splicing events for CD55, ENAH,
SIPA, Dystonin (DST), Reelin (RELN), and DRAM2. C, Expression of the PKM1 and PKM2 isoforms. Alternative exon levels are
normalized to a constitutive exon from the same gene (n ⫽ 6, data are mean ⫾ SEM, *p ⬍ 0.05, **p ⬍ 0.01, and
***p ⬍ 0.001).

Alterations in PFC function in VAChTdeficient mice
Galantamine was unable to rescue the attention deficits in VAChT Six3-Cre-flox/flox
mice. We have previously shown, using a
mouse line with decreased VAChT expression, that galantamine could reverse
social memory deficits (Prado et al., 2006)
and object recognition memory deficits
(de Castro et al., 2009b; De Jaeger et al.,
2013). Hence, the fact that galantamine can
improve performance of control mice, but
not of VAChT Six3-Cre-flox/flox mice, suggests
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that the latter may not release sufficient synaptic ACh to be enhanced by galantamine. Alternatively, these sophisticated tasks
may be more affected by changes in neuronal circuitry. The in
vivo 1H spectroscopy data suggest that critical metabolic changes
occur in VAChT-deficient mice; namely, reduced levels of both
Tau and Lac in the prefrontal region. Lac has been proposed as
the preferred metabolic substrate for neurons (for review, see
Pellerin et al., 2007), suggesting that decreased cholinergic tone
may lead to a general decrease in neuronal activity.
The reduction in PFC hnRNPA2/B1 observed in
VAChT Six3-Cre-flox/flox mice is in line with previous work indicating
cholinergic-mediated regulation of its expression in AD (Berson et
al., 2012). Furthermore, we found that alternative splicing alteration
pattern in the PFC of these mice is similar to the pattern found in
both AD patient samples and hypocholinergic animal models (Berson et al., 2012). Overall, these changes suggest alterations in the PFC
circuitry. Furthermore, the splicing change found in the PKM gene
indicates a potential mechanism for cholinergic regulation of Lac
metabolism. Of note, nearly significant differential expression of the
PKM variants was observed in exon array datasets from the entorhinal cortices of three AD patients and three matched controls studied
previously, despite the small number of samples (Berson et al., 2012;
p ⬍ 0.051; raw data deposited in the GenBank).
Decreased Lac levels have been observed in mouse models of
AD (Du Yan et al., 2000; Marjanska et al., 2005). Moreover, in the
CRND8 transgenic mouse model of AD, lower levels of Tau were
observed in vivo by H 1-NMR (Salek et al., 2010). Interestingly,
high levels of Lac in cultured neurons decrease susceptibility to
A␤-derived peptides and oxidative stress in vitro (Newington et
al., 2012). Together, these data suggest that VAChT Six3-Cre-flox/flox
mice may be useful for understanding metabolic abnormalities
that occur in dementia.
Conclusion
In summary, by eliminating VAChT from the forebrain we determined that cholinergic signaling regulates executive function,
affects metabolism, and also RNA processing in the PFC. The
PFC has been shown to mediate salient cue detection (Himmelheber et al., 2000; Parikh et al., 2007), and it serves as a hub that
regulates numerous neurotransmitter interactions (Dalley et al.,
2004a; Carr et al., 2007; Tait and Brown, 2008). Our work helps to
define the specific role played by ACh in behaviors related to
cortical functioning, and its potential underlying mechanisms.
Decreased levels of VAChT in the brain have been reported in AD
(Efange et al., 1997; Chen et al., 2011), therefore the executive
dysfunction and mRNA processing abnormalities we observed in
VAChT-deficient mice may be of relevance to model this specific
deficiency in humans. Therefore, this work provides novel insights into the basic neurochemical contributors governing executive function.
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